Chris Claxton, Vice President of Investor Relations and Corporate Communications at Horizon Discovery Group PLC (LON:HZD) talks to Proactive about the company entering into an agreement with an unnamed global molecular diagnostics provider to develop reference standards for non-invasive prenatal testing (NIPT).
Horizon Discovery Group inks 'significant' reference standards deal
Quick facts: Horizon Discovery Group PLC
Price: 156.4 GBX
Market Cap: £235.28 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE